ARISTO — Aristo Bio-Tech and Lifescience Share Price
Last trade - 00:00- IN₹932.67m
- IN₹1.13bn
- IN₹2.45bn
- 46
- 31
- 79
- 53
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.44 | ||
| Price to Tang. Book | 2.44 | ||
| Price to Free Cashflow | 89.21 | ||
| Price to Sales | 0.38 | ||
| EV to EBITDA | 13.28 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 14.72% | ||
| Return on Equity | 11.4% | ||
| Operating Margin | 2.82% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 2,012.31 | 1,672.18 | 1,659.9 | 2,178.56 | 2,451.48 | n/a | n/a | 3.98% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -64.38 | +6.78 | +33.74 | +147.61 | +9.36 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aristo Bio-Tech and Lifescience Limited is an India-based agrochemical company. The Company is engaged in the manufacturing, formulation, supplying, packaging and job work services in various pesticides, such as insecticides, herbicides, fungicides, plant growth regulators and a wide variety of other agrochemicals for India, as well as for export. It also exports crop protection products to various countries in finished / packaged goods, as well as bulk. It also provides contract manufacturing, job work and toll manufacturing services and products for reputed Indian and multinational crop protection companies. It has 257 products. Its insecticides crop protection products include Acephate 95% SG; Buprofezin 70% DF; Bifenthrin 2.5 % EC; Bifenthrin 8% SC; Chlorpyrifos 40.8 % EC, and others. The Company supplies its products across 20 states: Assam, Andhra Pradesh, Chhattisgarh, Gujarat, Haryana, Jammu & Kashmir, Jharkhand, Karnataka, Kerala, Maharashtra, Odisha, Punjab and others.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- March 17th, 2005
- Public Since
- January 30th, 2023
- No. of Employees
- 50
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 6,807,800
- Address
- E-24, Vadodara, 391775
- Web
- https://www.aristobiotech.com/
- Phone
- +91 2667299055
- Auditors
- Prakash Chandra Jain & Co.
Similar to ARISTO
20 Microns
National Stock Exchange of India
Aarti Industries
National Stock Exchange of India
Aarti Surfactants
National Stock Exchange of India
Abm International
National Stock Exchange of India
Advanced Enzyme Technologies
National Stock Exchange of India
FAQ
As of Today at 19:19 UTC, shares in Aristo Bio-Tech and Lifescience are trading at IN₹137.00. This share price information is delayed by 15 minutes.
Shares in Aristo Bio-Tech and Lifescience last closed at IN₹137.00 and the price had moved by +60.89% over the past 365 days. In terms of relative price strength the Aristo Bio-Tech and Lifescience share price has outperformed the S&P BSE 100 Index by +51.56% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Aristo Bio-Tech and Lifescience dividend yield is 0.29% based on the trailing twelve month period.
Last year, Aristo Bio-Tech and Lifescience paid a total dividend of IN₹0.40, and it currently has a trailing dividend yield of 0.29%. We do not have any data on when Aristo Bio-Tech and Lifescience is to next pay dividends.
We do not have data on when Aristo Bio-Tech and Lifescience is to next pay dividends. The historic dividend yield on Aristo Bio-Tech and Lifescience shares is currently 0.29%.
To buy shares in Aristo Bio-Tech and Lifescience you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹137.00, shares in Aristo Bio-Tech and Lifescience had a market capitalisation of IN₹932.67m.
Here are the trading details for Aristo Bio-Tech and Lifescience:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ARISTO
Based on an overall assessment of its quality, value and momentum Aristo Bio-Tech and Lifescience is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aristo Bio-Tech and Lifescience. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +9.73%.
As of the last closing price of IN₹137.00, shares in Aristo Bio-Tech and Lifescience were trading +21.82% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Aristo Bio-Tech and Lifescience PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹137.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Aristo Bio-Tech and Lifescience's directors